Physician

Scott Segel

According to 2025 Medicare claims, Scott Segel (NPI: 1063416535) practices endocrinology in the Williamsport, PA market, with the plurality of this provider's patient population coming from Lycoming, PA. This provider's primary affiliated billing organization is SUSQUEHANNA PHYSICIAN SERVICES (NPI: 1184652133; TIN: 232449454) and primary practice location at 17701-1909. Segel is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Segel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 419 traditional Medicare patients, billed 6,126 HCPCS/CPT codes, and received $157,974 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 5,454 prescription claims across 645 beneficiaries totaling $1,759,968 in drug costs, led by Ozempic (Semaglutide). DME data shows 826 claims. Open Payments data shows 11 records totaling $6,201. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $360,225 to $157,974. In contrast, Part D prescription costs have risen steadily, from $1,041,920 to $1,759,968. For DME billing, reported payments rose steadily, from $24,691 to $210,487.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	978	12,687	$360,225
2016	874	11,058	$304,758
2017	946	10,415	$295,100
2018	859	8,535	$241,138
2019	740	2,883	$98,574
2020	376	2,364	$80,664
2021	367	2,431	$108,419
2022	382	2,500	$105,734
2023	448	3,510	$126,629
2024	419	6,126	$157,974

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	415	3,282	$1,041,920
2016	539	3,991	$1,298,795
2017	548	4,436	$1,647,739
2018	520	4,519	$1,783,212
2019	746	3,579	$1,405,861
2020	463	3,312	$1,280,911
2021	424	3,449	$1,429,384
2022	452	3,593	$1,617,045
2023	595	4,336	$1,945,967
2024	645	5,454	$1,759,968

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	496	1,161	$53,578
2016	490	1,159	$54,490
2017	351	785	$64,670
2018	319	843	$96,234
2019	270	600	$48,280
2020	148	565	$66,830
2021	82	466	$71,501
2022	166	786	$149,964
2023	139	862	$174,529
2024	172	826	$224,275

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	52	52	$114
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	346	644	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	50	64	$62
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	75	152	$25
96372	Injection of drug or substance under skin or into muscle	36	85	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	396	16,539	$534,763
Jardiance	Empagliflozin	194	12,447	$235,301
Mounjaro	Tirzepatide	88	3,024	$106,168
Trulicity	Dulaglutide	77	3,220	$105,295
Farxiga	Dapagliflozin Propanediol	59	4,315	$76,674

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	86	479	$166,048
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	14	108	$19,014
E0784	External ambulatory infusion pump, insulin	Y	N/R	47	$16,469
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	16	52	$13,452
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	21	21	$4,275

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$6,201	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Scott Segel?

Tedicare shows public-source Medicare data for Scott Segel (NPI 1063416535), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott Segel have ACO affiliation data?

Scott Segel is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552).

What billing organization is linked to Scott Segel?

Scott Segel is linked to SUSQUEHANNA PHYSICIAN SERVICES (billing NPI 1184652133) in the available physician profile data.

Does Scott Segel have Open Payments data?

Scott Segel has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.